Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Thyroid Cancer, Papillary MeSH Descriptor Data 2026
An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer.
Entry Term(s)
Familial Nonmedullary Thyroid Cancer
Nonmedullary Thyroid Carcinoma
Papillary Carcinoma Of Thyroid
Papillary Thyroid Carcinoma
Thyroid Carcinoma, Papillary
NLM Classification #
WK 270
Public MeSH Note
2019; THYROID CANCER, PAPILLARY was indesed under THYROID NEOPLASMS and CARCINOMA, PAPILLARY 2010-2018
An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer.